All In Biotech

Drug Trial Radar · NCT03532542

An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy

Long-term, Open-label Extension Study for Patients With Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen

Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

171

Actual

Start

Aug 2, 2018

Primary completion

Jul 26, 2023

Study completion Jul 26, 2023

Sponsor

Lead sponsor
Sarepta Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
May 22, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 7 years, up to 23 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of this study is to evaluate the safety and tolerability of long-term treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).

Conditions

  • Duchenne Muscular Dystrophy

Interventions

  • CasimersenDrug

    Casimersen solution for IV infusion

  • GolodirsenDrug

    Golodirsen solution for IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-emergent Serious Adverse Events (TESAEs)Time frame: Up to 33 days after the last infusion of study drug (up to approximately 149 weeks)

Locations

50 sites in 13 countries. Site status is shown where the registry gives one.

  • Neuromuscular Research Center

    Phoenix, Arizona

  • Children's Hospital Los Angeles

    Los Angeles, California

  • University of California Los Angeles

    Los Angeles, California

  • Stanford Neuroscience Health Center

    Palo Alto, California

  • Rady Children's Hospital- San Diego

    San Diego, California

  • UF Health: University of Florida Clinical Research Center

    Gainesville, Florida

  • NW Florida Clinical Research Group, LLC

    Gulf Breeze, Florida

  • Rare Disease Research, LLC

    Atlanta, Georgia

  • Ann and Robert H Lurie Childrens Hospital of Chicago

    Chicago, Illinois

  • University of Iowa Childrens Hospital

    Iowa City, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Kennedy Krieger Institute

    Baltimore, Maryland

  • Boston Children's Hospital

    Boston, Massachusetts

  • St. Louis Children's Hospital

    St Louis, Missouri

  • Las Vegas Clinic

    Las Vegas, Nevada

  • University of Rochester Medical Center - Department of Neurology

    Rochester, New York

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Abigail Wexner Research Institute at Nationwide Children's Hospital

    Columbus, Ohio

  • Shriners Hospital for Children

    Portland, Oregon

  • Children's Hospital of Pittsburgh of UPMC

    Pittsburgh, Pennsylvania

  • Children's Medical Center Dallas

    Dallas, Texas

  • Texas Children's Hospital

    Houston, Texas

  • University of Utah - PPDS

    Salt Lake City, Utah

  • Children's Hospital of The King's Daughters

    Norfolk, Virginia

  • Children's Hospital of Wisconsin, Corporate Center Suite 540

    Milwaukee, Wisconsin

  • UZ Leuven

    Leuven, Belgium

  • UZ Gent

    Ghent, Oost-Vlaanderen, Belgium

  • University Multiprofile Hospital for active treatment Aleksandrovska EAD Clinic of Neurological Diseases

    Sofia, Bulgaria

  • Alberta Children's Hospital

    Calgary, Alberta, Canada

  • Children's Hospital of Eastern Ontario

    Ottawa, Ontario, Canada

  • Fakultni nemocnice Brno, Klinika detske neurologie LF MU a FN Brno

    Brno, Czechia

  • Fakultni nemocnice v Motole

    Prague, Czechia

  • Hotel Dieu- CHU Nantes

    Nantes, France

  • Hôpital Armand Trousseau

    Paris, France

  • Universitatsklinikum Freiberg

    Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • Universitatsklinikum Essen

    Essen, North Rhine-Westphalia, Germany

  • Schneider Children's Medical Center of Israel

    Petah Tikva, Israel

  • Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant' Anna

    Cona, Italy

  • Fondazione Policlinico Universitario A Gemelli

    Milan, Italy

  • UOSD Centro Traslazionale di Miologia e Patologie Neurogenerative

    Genoa, Liguria, Italy

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.